Upload
mariana-ungur
View
213
Download
0
Embed Size (px)
Citation preview
7/24/2019 Lab 3. the Management of
1/6
1
Lab.3.
THE MANAGEMENT OF
AN ACUTE EPISODE OF ASTHMA
The initial medical assessment of the severity of the current episode is critical to the acute management of
patients. Indicators of severity include:
ASTHMA HISTORY AND EXAMINATION
Increasing wheeze or dyspnoea, or respiratory distress with tachypnoea (>25 reaths!min" are clinical
features of worsening asthma. The patient#s own assessment may e important.Information regarding the
duration of episode, medication used pre$hospital, whether the patient regularly uses corticosteroids and
previous asthma episodes is important.
%ssessment of severity y patient or doctor on clinical oservation alone however, can e misleading and
should e ac&ed up y o'ective measurement. vidence for this comes from studies of perception of
asthma symptoms and from reviews of asthma deaths. %ssessment of all vital signs is important in
estalishing the level of severity of this episode of illness. %lthough the pulse rate may e elevated as aresult of some of the medication which has een administered, its elevation may also e due to the
severity of the underlying asthma episode.
Peak Expiratr! F"# Rate $PEF% Mea&'re(e)t&
These should e compared with either percentage of predicted normal values ()pred" or, if &nown, the
patient#s own est measurement
Ga& Ex*+a),e
*any adults re+uiring treatment for an acute asthma episode are hypoic! -ulse oimetry is a simplified
assessment of oygenation ut gives incomplete information. igh or rising arterial /02 (-a/02"pressures reflecting hypoventilation correlate with life$threatening asthma
There is some evidence to suggest that it may e reasonale to rely on oygen saturation (1p02"
measurement (pulse oimetry" alone at levels of 2 per cent or aove ut the evidence is not yet
conclusive
Therefore any patient in severe distress or who fails to respond to ronchodilator treatment should have
arterial lood gas (%34s" measurement.
C+e&t X-ra!
There is no indication for routine chest rays. /hest ray is re+uired if a respiratory complication issuspected from the clinical eamination (e.g. pneumothora, pneumonia".
"/ Te&t&
There is no indication that routine lood tests should e underta&en. -atients who have een classified as
severe and!or are re+uiring admission to I/6 should have creatinine 7 electrolytes and a full lood count.
7/24/2019 Lab 3. the Management of
2/6
2
S'((ar! G'i/e t E&tab"i&+i), t+e Le0e" 1 Se0erit! 1 t+i& epi&/e
8inding eamination
8inding
9evel 9evel of severity
1evere *oderate *ild
Triage /ategory ; or 2 < = or 5
/onscious 1tate *ay e altered ormal ormal
1pea&ing %ility ?ords!one -hrases 1entences
@espiratory rate (!min" >25 2A B 25 C2A
1a02 C2) 2 B 5) > 5)
%ir ntry -oor: may have
silent chest
*oderate 4ood
-8 ()pred or est
&nown value"
C2) should e started immediately in all patients.
Initial hypoia can ecome worse temporarily after ronchodilators. asal cannulae, although more
comfortale, deliver a variale level of enrichment. 4as flow provided through udson$type mas&s is
inade+uate when patients are tachypnoeic and a Henturi oygen system should e used. This leads to oth
an increase in the wor& of reathing and reduced inspired oygen concentration levels for the patient.
7/24/2019 Lab 3. the Management of
3/6
3
Crti*&teri/&
The use of corticosteroids in adults has een shown to improve outcome from acute asthma 6nder$use of
corticosteroids has een found in surveys of asthma deaths. Intravenous hydrocortisone has een shown
to e effective within 2 hours. 8or severe asthma episodes, the initial regimen recommended ishydrocortisone sodium succinate
7/24/2019 Lab 3. the Management of
4/6
4
1tudies have shown that for adult patients with severe asthma, an infusion of 2g of *g10= in addition to
standard steroid and neulised eta$agonist therapy, reduced admission rates and led to statistically
significant improvements in 8H; at oth ;2A and 2=A minutes.% similar finding for a weight$ased dose
of *g10= was made for children with asthma, not responding to standard therapy. These studies involved
small numers of patients and showed small ut statistically significant improvements in pulmonaryfunction.
-atients with severe asthma may receive *g10= 2g IH as an infusion over
7/24/2019 Lab 3. the Management of
5/6
5
This is the most convenient method of o'ective assessment. ?hen using -8 to evaluate response,
rememer the following:
L Initial values may overlap and e unreliale. owever, initial values, >5A )pred or patients est &nown
value, are unli&ely to result in admission.
L %fter initial treatment values, >FA )pred or patients est &nown value, will usually result in dischargehome from G.
Re*((e)/ati)& 1r ()itri), re&p)&e t i)itia" treat(e)t
;. 1igns of an inade+uate response $ respiratory rate, heart rate and oygen saturation. In those patients
who are not responding to treatment, arterial lood gas measurements should e initiated if not already
ta&en. (4rade /"
2. -ea& flow monitoring efore and after ronchodilator. (4rade /"
Di&p&iti) 1r( E(er,e)*! Depart(e)t
8rom G, patients may e admitted into acute wards of the hospital or discharged home. The decision to
admit will e ased on the severity of the presenting episode, the patients response to treatment and the
patients support system in the community.
H&pita" a/(i&&i)
ospital admission is more li&ely to e necessary if:
$ -a/02 is elevated at presentationD
$ -rolonged attac& of asthma of > 2= hours durationD
$ -resenting for medical attention, twice or more in a 2= hour periodD
$ 6se of regular oral corticosteroids at homeD
$ %ge > =A yearsD
$ -oor long term control.
I)ter(e/iate Re&piratr! Care U)it $IRCU% A&&e&&(e)t
-atients who present with a moderately severe episode of asthma and have a post treatment -8 of
etween
7/24/2019 Lab 3. the Management of
6/6
6
Di&*+ar,e 1 patie)t& 1r( t+e E(er,e)*! Depart(e)t t H(e
-atients who respond well to initial treatment will usually e discharged from G to home. *ost patients
suitale for discharge to home will have a -8 greater than FA )pred. or usual est.
-atients who do not respond +uic&ly to treatment or who have presented with a severe episode willusually e admitted into the hospital.
8or patients who are responding well to initial treatment discharge planning should commenceimmediately.
The patient#s previous asthma management should e reviewed and any specific cause of the acute
eaceration identified efore discharge. %ppropriate patient education and attention paid to longer$term
management at this stage are li&ely to reduce the fre+uency of further acute eacerations(5;$5